Showing results (311-320 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|April 30, 2023
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trialYuesong Pan, Xia Meng, Baoshi Yuan, et al.
The Lancet. Neurology|September 11, 2007
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trialNicholas A Di Prospero, Angela Baker, Neal Jeffries, et al.
The Lancet. Neurology|June 21, 2008
Autologous haematopoietic stem-cell transplantation in multiple sclerosisGianluigi Mancardi, Riccardo Saccardi
The Lancet. Neurology|June 21, 2008
CSF hypocretin-1 assessment in sleep and neurological disordersPatrice Bourgin, Jamie M Zeitzer, Emmanuel Mignot
The Lancet. Neurology|April 17, 2007
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised studyKa Sing Wong, Christopher Chen, Ping Wing Ng, et al.
The Lancet. Neurology|April 17, 2007
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data releaseMar Matarín, W Mark Brown, Sonja Scholz, et al.
The Lancet. Neurology|April 17, 2007
Antiepileptic drugs: generic versus branded treatmentsDominic C Heaney, Josemir W Sander
The Lancet. Neurology|September 22, 2007
Primary-progressive multiple sclerosisDavid H Miller, Siobhan M Leary
The Lancet. Neurology|September 22, 2007
Calcium, ageing, and neuronal vulnerability in Parkinson's diseaseD James Surmeier
The Lancet. Neurology|November 9, 2007
Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trialHans-Christoph Diener, Reto Agosti, Gianni Allais, et al.
Pageof 199